{"id":1044,"date":"2015-08-26T02:43:10","date_gmt":"2015-08-26T02:43:10","guid":{"rendered":"http:\/\/www.kurzweilai.net\/?p=260257"},"modified":"2015-08-27T03:56:51","modified_gmt":"2015-08-27T03:56:51","slug":"how-to-reprogram-cancer-cells-back-to-normal","status":"publish","type":"post","link":"https:\/\/hoo.central12.com\/fugic\/2015\/08\/26\/how-to-reprogram-cancer-cells-back-to-normal\/","title":{"rendered":"How to reprogram cancer cells back to normal"},"content":{"rendered":"<div id=\"attachment_260339\" class=\"wp-caption aligncenter\" style=\"width: 358px;  border: 1px solid #dddddd; background-color: #f3f3f3; padding-top: 4px; margin: 10px; text-align:center; display: block; margin-right: auto; margin-left: auto;\"><img class=\" wp-image-260339\" title=\"cell adhesion\" src=\"http:\/\/www.kurzweilai.net\/images\/cell-adhesion.jpg\" alt=\"\" width=\"348\" height=\"193\" \/><p style=' padding: 0 4px 5px; margin: 0;'  class=\"wp-caption-text\">Schematic of cell adhesion (credit: Wikipedia)<\/p><\/div>\n<p>A way to potentially reprogram cancer cells back to normalcy has been discovered by researchers on Mayo Clinic\u2019s Florida campus.<\/p>\n<p>The finding, published in\u00a0<a href=\"http:\/\/www.nature.com\/ncb\/journal\/vaop\/ncurrent\/full\/ncb3227.html\" ><em>Nature Cell Biology<\/em><\/a>, represents \u201can unexpected new biology that provides the code, the software for turning off cancer,\u201d says the study\u2019s senior investigator,\u00a0<a href=\"http:\/\/www.mayo.edu\/research\/faculty\/anastasiadis-panagiotis-z-ph-d\/bio-00092576?_ga=1.110841798.216396403.1389716336\" >Panos Anastasiadis, Ph.D.<\/a>, chair of the\u00a0<a href=\"http:\/\/www.mayo.edu\/research\/departments-divisions\/department-cancer-biology\/overview\" >Department of Cancer Biology<\/a>\u00a0on <a href=\"http:\/\/www.mayoclinic.org\/patient-visitor-guide\/florida?_ga=1.246032071.216396403.1389716336\" >Mayo Clinic\u2019s Florida campus<\/a>.<\/p>\n<div id=\"attachment_260341\" class=\"wp-caption aligncenter\" style=\"width: 358px;  border: 1px solid #dddddd; background-color: #f3f3f3; padding-top: 4px; margin: 10px; text-align:center; display: block; margin-right: auto; margin-left: auto;\"><img class=\" wp-image-260341\" title=\"microRNA regulation\" src=\"http:\/\/www.kurzweilai.net\/images\/microRNA-regulation.jpg\" alt=\"\" width=\"348\" height=\"203\" \/><p style=' padding: 0 4px 5px; margin: 0;'  class=\"wp-caption-text\">MicroRNAs &#8212; short, non-coding RNAs present in all living organisms that were formerly considered &#8220;junk DNA&#8221; &#8212; have been shown to regulate the expression of at least half of all human genes. These single-stranded RNAs exert their regulatory action by binding messenger RNAs and preventing their translation into proteins. (credit: Firefly BioWorks)<\/p><\/div>\n<p>That code was unraveled by the discovery that <a href=\"https:\/\/en.wikipedia.org\/wiki\/Cell_adhesion\" >adhesion proteins<\/a> &#8212; the glue that keeps cells together &#8212; interact with a key player in the production of molecules called <a href=\"https:\/\/en.wikipedia.org\/wiki\/MicroRNA\" >microRNAs<\/a> (miRNAs).<\/p>\n<p>The miRNAs orchestrate whole cellular programs by simultaneously regulating expression of a group of genes. The investigators found that when normal cells come in contact with each other, a specific subset of miRNAs suppresses (or blocks) genes that promote cell growth.<\/p>\n<p>However, when adhesion is disrupted in cancer cells, these miRNAs are misregulated and cells grow out of control. The investigators showed, in laboratory experiments, that restoring normal miRNA levels in cancer cells can reverse that aberrant cell growth.<\/p>\n<p>\u201cThe study brings together two so-far unrelated research fields \u2014 cell-to-cell adhesion and miRNA biology \u2014 to resolve a long-standing problem* about the role of adhesion proteins in cell behavior that was baffling scientists,\u201d says the study\u2019s lead author <a href=\"http:\/\/www.mayo.edu\/research\/labs\/cell-adhesion-metastasis\/faculty-staff\" >Antonis Kourtidis, Ph.D.<\/a>, a research associate in Anastasiadis\u2019 lab. \u201cMost significantly, it uncovers a new strategy for cancer therapy,\u201d he adds.<\/p>\n<p><strong><\/strong>\u201cBy administering the affected miRNAs in cancer cells to restore their normal levels, we should be able to re-establish the brakes and restore normal cell function,\u201d Anastasiadis says. \u201cInitial experiments in some aggressive types of cancer are indeed very promising.\u201d<\/p>\n<p><iframe frameborder=\"0\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/yGYTLOGZ40U?rel=0\" width=\"640\"><\/iframe><br \/>\n<em>Mayo Clinic | Mayo Clinic Researchers Find New Code That Makes Reprogramming of Cancer Cells Possible<\/em><\/p>\n<p><em>* That problem arose from conflicting reports about E-cadherin and p120 catenin &#8212; adhesion proteins that are essential for normal epithelial tissues to form, and which have long been considered to be tumor suppressors. <\/em><\/p>\n<p><em>\u201cHowever, we and other researchers had found that this hypothesis didn\u2019t seem to be true, since both E-cadherin and p120 are still present in tumor cells and required for their progression,\u201d Anastasiadis says. \u201cThat led us to believe that these molecules have two faces &#8212; a good one, maintaining the normal behavior of the cells, and a bad one that drives tumorigenesis.\u201d<\/em><\/p>\n<p><em>Their theory turned out to be true, but what was regulating this behavior was still unknown. To answer this, the researchers studied a new protein called PLEKHA7, which associates with E-cadherin and p120 only at the top, or the \u201capical\u201d part of normal polarized epithelial cells. The investigators discovered that PLEKHA7 maintains the normal state of the cells, via a set of miRNAs, by tethering the microprocessor to E-cadherin and p120. In this state, E-cadherin and p120 exert their good tumor suppressor sides.<\/em><\/p>\n<p><em>However, \u201cwhen this apical adhesion complex was disrupted after loss of PLEKHA7, this set of miRNAs was misregulated, and the E-cadherin and p120 switched sides to become oncogenic,\u201d Dr. Anastasiadis says.<\/em><\/p>\n<p><em>\u201cWe believe that loss of the apical PLEKHA7-microprocessor complex is an early and somewhat universal event in cancer,\u201d he adds. \u201cIn the vast majority of human tumor samples we examined, this apical structure is absent, although E-cadherin and p120 are still present. This produces the equivalent of a speeding car that has a lot of gas (the bad p120) and no brakes (the PLEKHA7-microprocessor complex).<\/em><\/p>\n<hr \/>\n<p><strong>Abstract of\u00a0<em>Distinct E-cadherin-based complexes regulate cell behaviour through miRNA processing or Src and p120 catenin activity<\/em><\/strong><\/p>\n<p>E-cadherin and p120 catenin (p120) are essential for epithelial homeostasis, but can also exert pro-tumorigenic activities. Here, we resolve this apparent paradox by identifying two spatially and functionally distinct junctional complexes in non-transformed polarized epithelial cells: one growth suppressing at the apical zonula adherens (ZA), defined by the p120 partner PLEKHA7 and a non-nuclear subset of the core microprocessor components DROSHA and DGCR8, and one growth promoting at basolateral areas of cell\u2013cell contact containing tyrosine-phosphorylated p120 and active Src. Recruitment of DROSHA and DGCR8 to the ZA is PLEKHA7\u00a0dependent. The PLEKHA7\u2013microprocessor complex co-precipitates with primary microRNAs (pri-miRNAs) and possesses pri-miRNA processing activity. PLEKHA7 regulates the levels of select miRNAs, in particular processing of miR-30b, to suppress expression of cell transforming markers promoted by the basolateral complex, including SNAI1, MYC and CCND1. Our work identifies a mechanism through which adhesion complexes regulate cellular behaviour and reveals their surprising association with the microprocessor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A way to potentially reprogram cancer cells back to normalcy has been discovered by researchers on Mayo Clinic&rsquo;s Florida campus. The finding, published in&nbsp;Nature Cell Biology, represents &ldquo;an unexpected new biology that provides the code, the software for turning off cancer,&rdquo; says the study&rsquo;s senior investigator,&nbsp;Panos Anastasiadis, Ph.D., chair of the&nbsp;Department of Cancer Biology&nbsp;on Mayo [&#8230;]<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42,43],"tags":[],"class_list":["post-1044","post","type-post","status-publish","format-standard","hentry","category-biotech","category-news"],"_links":{"self":[{"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/posts\/1044"}],"collection":[{"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/comments?post=1044"}],"version-history":[{"count":2,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/posts\/1044\/revisions"}],"predecessor-version":[{"id":1116,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/posts\/1044\/revisions\/1116"}],"wp:attachment":[{"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/media?parent=1044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/categories?post=1044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hoo.central12.com\/fugic\/wp-json\/wp\/v2\/tags?post=1044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}